Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

49
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
49
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

54
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
54
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.9K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.9K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

661
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
661
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

424
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
424
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.4K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nab-paclitaxel or Paclitaxel Treatment for Relapsed Small Cell Lung Cancer: A Single-arm Meta-analysis.

Anticancer research·2026
Same author

Reply to: Do current data justify the framing of respiratory fluoroquinolones and lascufloxacin in the 2024 JRS adult pneumonia guideline digest?

Respiratory investigation·2026
Same author

Impact of Resuscitative Endovascular Balloon Occlusion of the Aorta on In-Hospital and Short-Term Mortality: A Systematic Review and Meta-Analysis.

Diseases (Basel, Switzerland)·2026
Same author

Plaque regression and stabilization by proprotein convertase subtilisin/kexin type 9 inhibitors: a meta-analysis of intravascular imaging studies.

Coronary artery disease·2026
Same author

Utility of risk assessment and identification of risk factors for drug-resistant pathogens in hospital-acquired and ventilator-associated pneumonia: systematic reviews and meta-analyses.

Respiratory investigation·2026
Same author

Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.

Annals of the rheumatic diseases·2026
Same journal

Adenosine A<sub>2A</sub> receptor gene polymorphisms (ADORA2A) are associated with maximal concentric contraction pain.

Meta gene·2023
Same journal

Severity of coronavirus disease 19: Profile of inflammatory markers and <i>ACE</i> (rs4646994) and <i>ACE2</i> (rs2285666) gene polymorphisms in Iraqi patients.

Meta gene·2022
Same journal

Is there any relationship between serum zinc levels and angiotensin-converting enzyme 2 gene expression in patients with coronavirus disease 2019?

Meta gene·2021
Same journal

Interleukin-37 gene polymorphism and susceptibility to coronavirus disease 19 among Iraqi patients.

Meta gene·2021
Same journal

MicroRNAs based regulation of cytokine regulating immune expressed genes and their transcription factors in COVID-19.

Meta gene·2021
Same journal

Study of rare genetic variants in <i>TM4SF20, NFXL1, CNTNAP2,</i> and <i>ATP2C2</i> in Pakistani probands and families with language impairment.

Meta gene·2021
See all related articles

Related Experiment Video

Updated: Feb 27, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.4K

Genetic model selection for a case-control study and a meta-analysis.

Nobuyuki Horita1, Takeshi Kaneko1

  • 1Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Meta Gene
|June 5, 2015
PubMed
Summary
This summary is machine-generated.

This study addresses choosing the best genetic model for case-control studies. It explains how to select the optimal statistical model before calculating odds ratios (ORs) for genotype-disease associations, avoiding multiple comparison issues.

Keywords:
M, Major alleleMM, homozygote of major alleleMm, heterozygoteOR, odds ratiom, minor allelemm, homozygote of minor allele.

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.5K

Related Experiment Videos

Last Updated: Feb 27, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.4K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.5K

Area of Science:

  • Genetics
  • Epidemiology
  • Biostatistics

Background:

  • Case-control studies commonly assess disease prevalence by comparing allele and genotype frequencies between cases and controls.
  • Odds ratios (ORs) are frequently used to quantify disease risk associated with specific genotypes, such as major allele homozygotes (MM), heterozygotes (Mm), and minor allele homozygotes (mm).
  • Single-nucleotide polymorphisms (SNPs) represent the most common form of genetic variation.

Purpose of the Study:

  • To propose a method for selecting the most appropriate genetic model prior to calculating odds ratios (ORs) in genetic association studies.
  • To mitigate issues arising from multiple comparisons inherent in traditional approaches of evaluating multiple genetic models.

Main Methods:

  • Discussion of subject-level genetic models including dominant, multiplicative, recessive, and over-dominant models.
  • Emphasis on selecting the best-fitting model before calculating ORs for each genotype (MM, Mm, mm).
  • Utilizing two-by-two contingency tables for estimating ORs.

Main Results:

  • Traditional methods of calculating ORs across multiple models and then selecting the best one can lead to inflated Type I error rates due to multiple comparisons.
  • Selecting the optimal genetic model upfront is crucial for accurate and reliable estimation of genotype-disease associations.

Conclusions:

  • Choosing the best genetic model before calculating odds ratios is essential for robustly evaluating the impact of genotypes (MM/Mm/mm) on disease prevalence.
  • This approach enhances the statistical validity of findings in genetic epidemiology research.